Ebrahim Nasser B, Atteraya Madhu S
Department of Public Health.
Department of Social Welfare, Keimyung University, Dalseo-Gu, Daegu, South Korea.
J Public Health Res. 2021 Feb 8;10(1):1732. doi: 10.4081/jphr.2021.1732. eCollection 2021 Jan 14.
Oral rehydration salts (ORS) therapy for diarrheal diseases is considered an effective therapy that can be applied in many resource-poor settings. Nevertheless, it has been consistently underutilized, and as a result, its potential to reduce child mortality has not been fully exploited. In Ethiopia, the use of ORS therapy for children under five has been inadequate. Like any other health behavior, the provision of ORS therapy to children during diarrheal episodes by caregivers is complex and context dependent. Identifying the factors may help promote wider application. We used data from the 2016 Ethiopia Demographic and Health Survey (EDHS-2016). Samples were selected by a two-stage stratified cluster sampling method. We used data on children under five years of age whose mothers (aged 15-49 years) reported that the child had had diarrhea within two weeks before the survey was conducted (n=1221). The dependent variable was whether these children received ORS therapy. The contextual independent factors were socio-demographic variables (mothers' age, child's age, child's sex, child's place of residence, household wealth, and mother/ husband/partner's education levels and work status), as well as media exposure and healthcare utilization. The prevalence of ORS therapy use among the children was 30%. Mothers who had made at least four prenatal visits during their last pregnancy were 87% more likely to use ORS therapy for their children than those who had fewer prenatal visits (OR=1.874; CI: 1.140-3.082; p=0.013). Integrating efforts for scaling-up ORS use with prenatal health care services may have an extra benefit of promoting children's wellbeing and survival.
口服补液盐(ORS)疗法用于治疗腹泻病,被认为是一种有效的疗法,可应用于许多资源匮乏的地区。然而,该疗法一直未得到充分利用,因此,其降低儿童死亡率的潜力尚未得到充分发挥。在埃塞俄比亚,五岁以下儿童口服补液盐疗法的使用并不充分。与任何其他健康行为一样,照顾者在儿童腹泻期间为其提供口服补液盐疗法的情况复杂且因具体情况而异。确定这些因素可能有助于促进该疗法的更广泛应用。我们使用了2016年埃塞俄比亚人口与健康调查(EDHS - 2016)的数据。样本通过两阶段分层整群抽样方法选取。我们使用了五岁以下儿童的数据,这些儿童的母亲(年龄在15 - 49岁之间)报告称孩子在调查进行前两周内患过腹泻(n = 1221)。因变量是这些儿童是否接受了口服补液盐疗法。背景独立因素包括社会人口统计学变量(母亲年龄、孩子年龄、孩子性别、孩子居住地点、家庭财富以及母亲/丈夫/伴侣的教育水平和工作状况),以及媒体曝光和医疗保健利用情况。这些儿童中口服补液盐疗法的使用率为30%。在最后一次怀孕期间至少进行过四次产前检查的母亲,为孩子使用口服补液盐疗法的可能性比产前检查次数较少的母亲高87%(OR = 1.874;CI:1.140 - 3.082;p = 0.013)。将扩大口服补液盐使用的努力与产前保健服务相结合,可能会带来促进儿童健康和生存的额外益处。